Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000310158-25-000059
Filing Date
2025-11-05
Accepted
2025-11-05 16:08:41
Documents
97
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 3Q25 FORM 10-Q mrk-20250930.htm   iXBRL 10-Q 3072286
2 EX-31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO exhibit311-rule13ax14a15dx.htm EX-31.1 8393
3 EX-31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO exhibit312-rule13ax14a15dx.htm EX-31.2 8239
4 EX-32.1 SECTION 1350 CERTIFICATION OF CEO exhibit321-section1350cert.htm EX-32.1 3876
5 EX-32.2 SECTION 1350 CERTIFICATION OF CFO exhibit322-section1350cert.htm EX-32.2 3724
  Complete submission text file 0000310158-25-000059.txt   16466845

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrk-20250930.xsd EX-101.SCH 77535
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrk-20250930_cal.xml EX-101.CAL 91335
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrk-20250930_def.xml EX-101.DEF 522562
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrk-20250930_lab.xml EX-101.LAB 850687
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrk-20250930_pre.xml EX-101.PRE 722136
100 EXTRACTED XBRL INSTANCE DOCUMENT mrk-20250930_htm.xml XML 4009782
Mailing Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065
Business Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06571 | Film No.: 251453989
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)